GLYCOMIMETICS, INC.
Patent Owner
Stats
- 29 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 29 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,130 Total Citation Count
- May 05, 1994 Earliest Filing
- 22 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0296,566 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITISSep 29, 14Oct 19, 17[A61K, C07H]
2016/0333,043 E-Selectin Antagonists Modified By Macrocycle Formation to the GalactoseJan 15, 15Nov 17, 16[C07H]
2016/0184,339 Compounds, Compositions and Methods Using E-Selectin Antagonists for Mobilization of Hematopoietic CellsDec 05, 13Jun 30, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9867841 Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cellsDec 05, 13Jan 16, 18[A61K]
9796745 E-selectin antagonist compounds, compositions, and methods of useJun 26, 15Oct 24, 17[A61K, C07H]
9534009 Pan-selectin inhibitor with enhanced pharmacokinetic activityOct 28, 14Jan 03, 17[A61K, C07H]
9109002 E-selectin antagonist compounds, compositions, and methods of useDec 21, 12Aug 18, 15[C07H, A61K]
8895510 Pan-selectin inhibitor with enhanced pharmacokinetic activityApr 06, 09Nov 25, 14[A61K, C07H, A61P]
8530448 Compounds and methods for inhibiting selectin-mediated functionApr 02, 10Sep 10, 13[A61K, C07H]
8518896 Treatment of cancers of the blood using selected glycomimetic compoundsJun 10, 09Aug 27, 13[A61K, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0331,775 E-SELECTIN INHIBITION WORKS IN COMBINATION WITH LOW-MOLECULAR WEIGHT HEPARIN TO DECREASE VENOUS THROMBOSIS AND BLEEDING RISKAbandonedMay 13, 16Nov 17, 16[A61K]
2014/0073,594 GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIVAbandonedNov 15, 13Mar 13, 14[C07H]
2013/0184,229 HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORSAbandonedMar 05, 13Jul 18, 13[C07H]
2012/0329,755 GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONASAbandonedAug 03, 12Dec 27, 12[A61K, C08B, A61P]
2012/0202,762 METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINESAbandonedSep 02, 11Aug 09, 12[A61K, A61P]
2011/0257,380 GLYCOMIMETIC REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINESAbandonedApr 25, 11Oct 20, 11[C07H]
2011/0251,148 GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIVAbandonedApr 06, 11Oct 13, 11[A61K, C07H, A61P]
2011/0027,180 DETECTION AND TREATMENT OF PROSTATE CANCERAbandonedApr 13, 10Feb 03, 11[A61K, G01N, A61P]
2009/0176,717 GALACTOSIDES AND THIODIGALACTOSIDES AS INHIBITORS OF PA-IL LECTIN FROM PSEUDOMONASAbandonedMay 30, 07Jul 09, 09[A61K, C12N, G01N]
2009/0036,386 Heterobifunctional compounds for selectin inhibitionAbandonedMay 24, 06Feb 05, 09[A61K, C07H]
2005/0187,171 Glycomimetic antagonists for both E-and P-selectinsAbandonedNov 18, 04Aug 25, 05[A61K]
2004/0219,158 Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteriaAbandonedDec 19, 03Nov 04, 04[A61K]
2004/0096,396 Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesisAbandonedJun 19, 03May 20, 04[A61K]
6465434 Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion moleculesExpiredNov 23, 99Oct 15, 02[A01N]
6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancersExpiredAug 23, 99Aug 28, 01[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
